Latest Rhinitis Stories
OXFORD, England, October 2 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on the fields of allergy and critical care, today announced the start of a further phase II clinical study of its ToleroMune(R) technology in the field of cat allergy.
Breathe Again(TM), Europe's best selling hypertonic saline nasal spray, is now available in the United States. Clinically tested in France, Breathe Again (www.breatheagain.us) is 100% natural, combining the benefits of pure seawater and the drying effect of a hypertonic solution.
Sanofi-Aventis has announced that the FDA has approved Nasacort AQ nasal spray for children aged two to five years old for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis.
Nasacort, a nasal steroid used in allergic rhinitis, has been approved for the treatment of children aged two to five years old.
BRIDGEWATER, N.J., Sept. 23 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today the U.S.
A COMMON painkiller may be one of the key driving forces behind the worldwide epidemic of childhood asthma, reveals a major study today.
OXFORD, England, September 10 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on controlling immune system responses, today announced positive results from a phase II clinical study of its anti-allergy technology, ToleroMune(R), in the field of cat allergy.
An allergy educational group has named Greensboro, N.C., as the most challenging place to live for people with seasonal allergies.
Orexo, a Swedish pharmaceutical company, has initiated a Phase II program for the product OX914, a new candidate for the treatment of inflammatory airway diseases including asthma, chronic obstructive pulmonary disease and rhinitis.
ANTONY, France, August 27 /PRNewswire-FirstCall/ -- - Oralair(R) Grasses 300IR Highly Positive Clinical Results in a Pharmacodynamic Study Conducted in an Allergen Challenge Chamber Stallergenes S.A.
- A handkerchief.
- In general, any miraculous portrait of Christ.